| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/03/2001 | US6211334 Cell-cycle regulatory proteins, and uses related thereto |
| 04/03/2001 | US6211163 Injection; sustained release of expressed protein |
| 04/03/2001 | US6211161 UDP-N-acetylmuramoyl-l-alanine:D-glutamate ligase (MURD) of staphylococcus aureus |
| 04/03/2001 | US6211159 Flagellin gene, FlaC of campylobacter |
| 04/03/2001 | US6211157 Administering bone-derived protein; ultrafiltration, ion exchanging, liquid chromatography |
| 04/03/2001 | US6211155 Stimulating immune system with peptides conjugated with mono-or dicarboxylic acid; |
| 04/03/2001 | US6211151 Peptides with organo-protective activity, a process for preparation thereof and their use in therapy |
| 04/03/2001 | US6211150 Analogs of cationic proteins |
| 04/03/2001 | US6211149 Inhibitors of formation of protease resistant prion protein |
| 04/03/2001 | US6211148 Antimicrobial peptides from bovine neutrophis |
| 04/03/2001 | US6211146 60A protein-induced morphogenesis |
| 04/03/2001 | US6211142 Compositions comprising gas6 polypeptides and articles of manufacture comprising the same |
| 04/03/2001 | US6210968 DNA molecules encoding pgp3 protein from Chlamydia trachomatis |
| 04/03/2001 | US6210967 DNA encoding a mammalian LPA receptor and uses thereof |
| 04/03/2001 | US6210965 Cell culture process and medium, cellular composition obtained and its application as production system and study model |
| 04/03/2001 | US6210964 Nucleotide sequence coding binding protein; for controlling serum calcification in animals |
| 04/03/2001 | US6210963 Autologous differentiated tissue aggregates; for the treatment of tumors; antitumor agents |
| 04/03/2001 | US6210962 Nucleotide and peptide sequences of an isolate of the hepatitis C virus, diagnostic and therapeutic applications thereof |
| 04/03/2001 | US6210960 Nucleotide sequence coding polypeptide which activates somatostatin promote; for the treatment of diabetes |
| 04/03/2001 | US6210954 Microorganism cultures; for the generation of heterologous proteins |
| 04/03/2001 | US6210953 Bacillus thuringiensis isolate BTC-18 with broad spectrum activity |
| 04/03/2001 | US6210952 Bacillus thuringiensis mutants which produce higher yields of crystal delta-endotoxin than their corresponding parental strains |
| 04/03/2001 | US6210948 Nucleotide sequence coding a bacterial protein; for utilization in bioreactors |
| 04/03/2001 | US6210942 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 04/03/2001 | US6210939 Recombinant adenoviral vector and methods of use |
| 04/03/2001 | US6210929 Fusion protein of furin with catalytic center and c-terminal deletion, flexible peptide spacer, and histidine-tag affinity peptide; for proteolytic processing/activation of recombinant proteins |
| 04/03/2001 | US6210928 Production of proteins in procaryotes |
| 04/03/2001 | US6210926 Activating apoptosis in cell infected with herpes by in vitro administration of agent that inhibits infected cell protein-4 function |
| 04/03/2001 | US6210925 Direct expression of peptides into culture media |
| 04/03/2001 | US6210924 Overexpressing cyclin D 1 in a eukaryotic cell line |
| 04/03/2001 | US6210923 Mammalian circadian regulator M-RIGUI2 (MPER2) |
| 04/03/2001 | US6210922 Serum free production of recombinant proteins and adenoviral vectors |
| 04/03/2001 | US6210921 CAR: a novel coxsackievirus and adenovirus receptor |
| 04/03/2001 | US6210920 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 04/03/2001 | US6210919 Genetic sequences and proteins related to alzheimer's disease |
| 04/03/2001 | US6210914 Method to identify proteins which bind to integrin regulatory proteins |
| 04/03/2001 | US6210913 Modulation of integrin-mediated signal transduction |
| 04/03/2001 | US6210908 Solid support for use in immunoassays, especially against human immunodeficiency virus; a cyclic peptide linked through a 3-sulfide-succinimide moiety to a protein, enzyme, or antibody |
| 04/03/2001 | US6210905 Antigen binding region of antibody which binds epitope of defined amino acid sequence; for detecting the protein in biological sample |
| 04/03/2001 | US6210903 Amino acid sequence which is optionally modified and biotinylated |
| 04/03/2001 | US6210902 Using two immunoassays to measure two different type 1 collagen breakdown products of defined amino acid sequence in sample and forming an index representing the difference in results; diagnosis of bone disorders such as osteoporosis |
| 04/03/2001 | US6210901 Modified hepatitis c virus amino acid sequence which binds to an antibody; for screening blood samples |
| 04/03/2001 | US6210899 Use of a BMP protein receptor complex for screening bone metabolism actives and cells co-transfected with a type II BMP receptor and type I BMP receptor |
| 04/03/2001 | US6210898 Using strip of porous material which transports sample liquid by capillary action to several unique capture reagents immobilized in discrete spaced apart spots, then determining binding of analyte at the spots |
| 04/03/2001 | US6210897 Identification of canine leukocyte adhesion deficiency in dogs |
| 04/03/2001 | US6210887 Methods for evaluating colon tissue for expression of the DRA (down regulated in adenoma) gene |
| 04/03/2001 | US6210883 Compounds and methods for diagnosis of lung cancer |
| 04/03/2001 | US6210877 Prediction of coronary artery disease |
| 04/03/2001 | US6210874 Synthetic peptides and mixtures thereof for detecting HIV antibodies |
| 04/03/2001 | US6210873 Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
| 04/03/2001 | US6210736 Transgenically produced prolactin |
| 04/03/2001 | US6210685 Acellular whooping cough vaccines. |
| 04/03/2001 | US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed. |
| 04/03/2001 | US6210676 Compositions and methods using the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein C (OspC) for the diagnosis and prevention of lyme disease |
| 04/03/2001 | US6210675 Post-transfusional non-a non-b hepatitis viral polypeptide |
| 04/03/2001 | US6210674 GreA from Staphylococcus aureus |
| 04/03/2001 | US6210673 gidB from Staphylococcus aureus |
| 04/03/2001 | US6210667 Relates to modifications of streptokinase and other microbial enzymes for use to activate plasminogen in the presence of fibrin, to efficiently dissolve an unwanted blood clot in a subject. |
| 04/03/2001 | US6210662 Fusion protein having prostatic acid phosphatase (pap) as an n-terminal moiety and gm-csf as a c-terminal moiety, and wherein said cells are effective to activate t-cells to produce a multivalent cytotoxic cellular immune response |
| 04/03/2001 | CA2239733C Chromosome 13-linked breast cancer susceptibility gene |
| 04/03/2001 | CA2224795C Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/03/2001 | CA2196795C Method for diagnosing a predisposition for breast and ovarian cancer |
| 04/03/2001 | CA2194228C Fusion proteins comprising gm-csf and antigens and their expression in yeast |
| 04/03/2001 | CA2188280C Regulatory element conferring tapetum specificity |
| 04/03/2001 | CA2183371C Pna combinatorial libraries and improved methods of synthesis |
| 04/03/2001 | CA2163755C Dna encoding prostaglandin receptor ep1 |
| 04/03/2001 | CA2153180C Interleukin 4 signal transducers and binding assays |
| 04/03/2001 | CA2118043C Immortalized human cell lines containing exogenous cytochrome p450 genes |
| 04/01/2001 | CA2319853A1 Floral homeotic genes for manipulation of flowering in poplar trees and other plant species |
| 03/30/2001 | CA2283538A1 New hev antigenic peptide and methods |
| 03/29/2001 | WO2001022092A2 Method to identify compounds which modulate fra-1 expression fils |
| 03/29/2001 | WO2001022090A1 Method for identifying compounds useful in the therapy of bone disorders |
| 03/29/2001 | WO2001022085A1 Method of fractional measurement of soluble cd14 protein |
| 03/29/2001 | WO2001021836A2 Molecules for diagnostics and therapeutics |
| 03/29/2001 | WO2001021828A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | WO2001021822A1 Methods and means for modification of plant flowering characteristics |
| 03/29/2001 | WO2001021821A2 Insect-resistant rice plants |
| 03/29/2001 | WO2001021816A1 MODULATION OF IgE RECEPTOR CELL SURFACE EXPRESSION |
| 03/29/2001 | WO2001021811A1 Dna immunization against chlamydia infection |
| 03/29/2001 | WO2001021807A1 Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof |
| 03/29/2001 | WO2001021806A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021805A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021803A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021802A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021798A2 Nucleic acid encoding human abca transporter 2 (abca2) and methods of use thereof |
| 03/29/2001 | WO2001021797A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | WO2001021796A2 Gl50 molecules and uses therefor |
| 03/29/2001 | WO2001021795A2 Fatty acid transport proteins |
| 03/29/2001 | WO2001021794A2 Smad associating polypeptides |
| 03/29/2001 | WO2001021792A1 Transporter genes oatp-b, c, d and e |
| 03/29/2001 | WO2001021791A2 Stargazin-like neuronal ca2+-channel gamma subunit polypeptides |
| 03/29/2001 | WO2001021790A1 Conditional immortalisation of cells |
| 03/29/2001 | WO2001021788A1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 03/29/2001 | WO2001021787A1 Polypeptide humanin inhibiting nerve cell death |
| 03/29/2001 | WO2001021786A1 Method of screening disease depressant gene |
| 03/29/2001 | WO2001021785A2 Megagametophyte transcriptional control elements and uses thereof |
| 03/29/2001 | WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021783A2 Seed-preferred promoter from maize |